Improvement of the antiproliferative effect of Rapamycin on tumor cell lines by poly (monomethylitaconate)-based pH-sensitive, plasma stable liposomes

Colloids and Surfaces B: Biointerfaces

Volumn 115, Issue , 2014, Pages 323-330

  Ghanbarzadeh, Saeed ^a,b   Arami, Sanam ^a,b   Pourmoazzen, Zhaleh ^c   Khorrami, Arash ^a,b  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c AZARBAIJAN SHAHID MADANI UNIVERSITY   (Iran)

Author keywords

Cancer; Copolymer; PH sensitive liposome; Plasma stability; Rapamycin

Indexed keywords

ANTIPROLIFERATIVE AGENTS; ANTIPROLIFERATIVE EFFECT; CANCER; HUMAN UMBILICAL VEIN ENDOTHELIAL (HUVEC) CELLS; MILD ACIDIC CONDITIONS; PH-SENSITIVE LIPOSOMES; PHYSICO-CHEMICAL STABILITY; RAPAMYCIN;

CELL CULTURE; CELLS; COPOLYMERS; LIPOSOMES; PLASMA STABILITY; PLASMAS; POLYETHYLENE GLYCOLS; POLYETHYLENE OXIDES;

PH EFFECTS;

LIPOSOME; MACROGOL; POLY(MONOMETHYLITACONATE); POLYMER; RAPAMYCIN; UNCLASSIFIED DRUG; CHOLESTEROL; DIPALMITOYLPHOSPHATIDYLCHOLINE; ITACONIC ACID; MACROGOL DERIVATIVE; OLEIC ACID; POLYVINYL DERIVATIVE; SUCCINIC ACID DERIVATIVE;

ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; DRUG EFFECT; DRUG FORMULATION; DRUG STABILITY; ENCAPSULATION; HUMAN; HUMAN CELL; INCUBATION TIME; LIPOSOMAL DELIVERY; PARTICLE SIZE; PH MEASUREMENT; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; TIMED DRUG RELEASE; UMBILICAL VEIN ENDOTHELIAL CELL; ZETA POTENTIAL; ANALOGS AND DERIVATIVES; BLOOD; CELL PROLIFERATION; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; METABOLISM; PH; SYNTHESIS; TUMOR CELL LINE;

1,2-DIPALMITOYLPHOSPHATIDYLCHOLINE; CELL LINE, TUMOR; CELL PROLIFERATION; CHOLESTEROL; DRUG STABILITY; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; LIPOSOMES; OLEIC ACID; POLYETHYLENE GLYCOLS; POLYVINYLS; SIROLIMUS; SUCCINATES;

EID: 84891691816     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.12.024     Document Type: Article

References (62)

1. Liu R., Li D., He B., Xu X., Sheng M., Lai Y., Wang G., Gu Z. Anti-tumor drug delivery of pH-sensitive poly(ethylene glycol)-poly(L-histidine-)-poly(L-lactide) nanoparticles. J. Control. Release 2011, 152:49-56.
2. Shen M., Huang Y., Han L., Qin J., Fang X., Wang J., Yang V.C. Multifunctional drug delivery system for targeting tumor and its acidic microenvironment. J. Control. Release 2012, 161:884-892.
3. Yu S., Wu G., Gu X., Wang J., Wang Y., Gao H., Ma J. Magnetic and pH-sensitive nanoparticles for antitumor drug delivery. Colloids Surf. B: Biointerfaces 2013, 103:15-22.
4. Biswas S., Dodwadkar N.S., Deshpande P.P., Torchilin V.P. Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo. J. Control. Release 2012, 159:393-402.
5. Elbayoumi T.A., Torchilin V.P. Enhanced cytotoxicity of monoclonal anticancer antibody 2C5-modified doxorubicin-loaded PEGylated liposomes against various tumor cell lines. Eur. J. Pharm. Sci. 2007, 32:159-168.
6. Nagayasu A., Uchiyama K., Kiwada H. The size of liposomes: a factor which affects their targeting efficiency to tumors and therapeutic activity of liposomal antitumor drugs. Adv. Drug Del. Rev. 1999, 40:75-87.
7. Wright S., Huang L. Antibody-directed liposomes as drug-delivery vehicles. Adv. Drug Del. Rev. 1989, 3:343-389.
8. Gerasimov O.V., Boomer J.A., Qualls M.M., Thompson D.H. Cytosolic drug delivery using pH- and light-sensitive liposomes. Adv. Drug Del. Rev. 1999, 38:317-338.
9. Simões S., Moreira J.N., Fonseca C., Düzgüneş N., Pedroso de Lima M.C. On the formulation of pH-sensitive liposomes with long circulation times. Adv. Drug Del. Rev. 2004, 56:947-965.
10. Edwards J., Brown D.T. Sindbis virus infection of a Chinese hamster ovary cell mutant defective in the acidification of endosomes. Virology 1991, 182:28-33.
11. Gay B., Bernard E., Solignat M., Chazal N., Devaux C., Briant L. pH-dependent entry of chikungunya virus into Aedes albopictus cells. Infect. Genet. Evol. 2012, 12:1275-1281.
12. Singh R.S., Gonçalves C., Sandrin P., Pichon C., Midoux P., Chaudhuri A. On the gene delivery efficacies of pH-sensitive cationic lipids via endosomal protonation: a chemical biology investigation. Chem. Biol. 2004, 11:713-723.
13. Drummond D.C., Zignani M., Leroux J.-C. Current status of pH-sensitive liposomes in drug delivery. Prog. Lipid Res. 2000, 39:409-460.
14. Simard P., Leroux J.-C. pH-sensitive immunoliposomes specific to the CD33 cell surface antigen of leukemic cells. Int. J. Pharm. 2009, 381:86-96.
15. Yuba E., Harada A., Sakanishi Y., Kono K. Carboxylated hyperbranched poly(glycidol)s for preparation of pH-sensitive liposomes. J. Control. Release 2011, 149:72-80.
16. Zhou W., An X., Wang J., Shen W., Chen Z., Wang X. Characteristics, phase behavior and control release for copolymer-liposome with both pH and temperature sensitivities. Colloids Surf. Physicochem. Eng. Aspects 2012, 395:225-232.
17. Collins D., Connor J., Ting-Beall H.-P., Huang L. Proton and divalent cations induce synergistic but mechanistically different destabilizations of pH-sensitive liposomes composed of dioleoyl phosphatidylethanolamine and oleic acid. Chem. Phys. Lipids 1990, 55:339-349.
18. Leroux J.-C., Roux E., Le Garrec D., Hong K., Drummond D.C. N-isopropylacrylamide copolymers for the preparation of pH-sensitive liposomes and polymeric micelles. J. Control. Release 2001, 72:71-84.
19. Roux E., Francis M., Winnik F.M., Leroux J.-C. Polymer based pH-sensitive carriers as a means to improve the cytoplasmic delivery of drugs. Int. J. Pharm. 2002, 242:25-36.
20. Srisuk P., Thongnopnua P., Raktanonchai U., Kanokpanont S. Physico-chemical characteristics of methotrexate-entrapped oleic acid-containing deformable liposomes for in vitro transepidermal delivery targeting psoriasis treatment. Int. J. Pharm. 2012, 427:426-434.
21. Bagheri M., Pourmoazzen Z., Entezami A.A. Synthesis, characterization and liquid crystalline behavior of poly(monomethyl itaconate)s with new pendant cholesterol moieties. Iran Polym. J. 2013, 22:303-311.
22. Bagheri M., Pourmoazzen Z., Entezami A.A. pH-responsive nanosized-micelles based on poly (monomethylitaconate)-co-poly(dimethylaminoethyl methacrylate) and cholesterol side chains effect on pH change-induced release of piroxicam. J. Polym. Res. 2013, Accepted.
23. Pourmoazzen Z., Bagheri M., Entezami A.A., Nejati Koshki K. pH-responsive micelles composed of poly(ethylene glycol) and cholesterol-modified poly(monomethyl itaconate) as a nanocarrier for controlled and targeted release of piroxicam. J. Polym. Res. 2013, Accepted.
24. Ishida T., Okada Y., Kobayashi T., Kiwada H. Development of pH-sensitive liposomes that efficiently retain encapsulated doxorubicin (DXR) in blood. Int. J. Pharm. 2006, 309:94-100.
25. Løkling K.-E., Skurtveit R., Fossheim S.L., Smistad G., Henriksen I., Klaveness J. pH-sensitive paramagnetic liposomes for MRI: assessment of stability in blood. Magn. Reson. Imaging 2003, 21:531-540.
26. Vieira F.P., Mesquita T.L., Lara P.C.P., Ramaldes G.A., Beinner M.A., Silva J.B.B., Oliveira M.C., Silveira J.N. ET AAS. evaluation of the stability and pH-sensitivity of, pH-sensitive stealth liposomes containing cisplatin in mouse plasma. J. Pharm. Biomed. Anal. 2013, 84:135-139.
27. Gref R., Domb A., Quellec P., Blunk T., Müller R.H., Verbavatz J.M., Langer R. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Adv. Drug Del. Rev. 2012, 64(Supplement):316-326.
28. Parveen S., Sahoo S.K. Long circulating chitosan/PEG blended PLGA nanoparticle for tumor drug delivery. Eur. J. Pharmacol. 2011, 670:372-383.
29. Sheng Y., Liu C., Yuan Y., Tao X., Yang F., Shan X., Zhou H., Xu F. Long-circulating polymeric nanoparticles bearing a combinatorial coating of PEG and water-soluble chitosan. Biomaterials 2009, 30:2340-2348.
30. Cole A.J., David A.E., Wang J., Galbán C.J., Yang V.C. Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles. Biomaterials 2011, 32:6291-6301.
31. Torchilin V.P. PEG-based micelles as carriers of contrast agents for different imaging modalities. Adv. Drug Del. Rev. 2002, 54:235-252.
32. Wu H., Zhu L., Torchilin V.P. pH-sensitive poly(histidine)-PEG/DSPE-PEG co-polymer micelles for cytosolic drug delivery. Biomaterials 2013, 34:1213-1222.
33. Abraham R.T. Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling. Curr. Opin. Immunol. 1998, 10:330-336.
34. Powers J.F., Tischler A.S., Cherington V. Discordant effects of rapamycin on proliferation and p70S6 kinase phosphorylation in normal and neoplastic rat chromaffin cells. Neurosci. Lett. 1999, 259:137-140.
35. Sehgal S.N. Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin. Biochem. 1998, 31:335-340.
36. Thomson A.W. The immunosuppressive macrolides FK-506 and rapamycin. Immunol. Lett. 1991, 29:105-111.
37. Bae-Jump V.L., Zhou C., Boggess J.F., Whang Y.E., Barroilhet L., Gehrig P.A. Rapamycin inhibits cell proliferation in type I and type II endometrial carcinomas: a search for biomarkers of sensitivity to treatment. Gynecol. Oncol. 2010, 119:579-585.
38. Butzal M., Loges S., Schweizer M., Fischer U., Gehling U.M., Hossfeld D.K., Fiedler W. Rapamycin inhibits proliferation and differentiation of human endothelial progenitor cells in vitro. Exp. Cell Res. 2004, 300:65-71.
39. Chang S.B., Miron P., Miron A., Iglehart J.D. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells. J. Surg. Res. 2007, 138:37-44.
40. Law B.K. Rapamycin: an anti-cancer immunosuppressant?. Crit. Rev. Oncol./Hematol. 2005, 56:47-60.
41. Shirouzu Y., Ryschich E., Salnikova O., Kerkadze V., Schmidt J., Engelmann G. Rapamycin inhibits proliferation and migration of hepatoma cells in vitro. J. Surg. Res. 2010, 159:705-713.
42. Islambulchilar Z., Ghanbarzadeh S., Emami S., Valizadeh H., Zakeri-Milani P. Development and validation of an HPLC method for the analysis of sirolimus in drug products. Adv. Pharmaceut. Bull. 2012, 2:135-139.
43. Gargallo L., Yazdani-Pedram M., Radić D., Horta A., Bravo J. Properties of polyelectrolytes-2. Poly(monoethyl itaconate), conformational and viscometric behaviour in dilute solution. Eur. Polym. J. 1993, 29:609-612.
44. Radić D., Gargallo L. Thermal behaviour of polymer blends containing poly(mono-itaconates) and poly(thiocarbonates). Thermochim. Acta 1991, 180:241-249.
45. Bagheri M., Pourmoazzen Z., Entezami A.A. Synthesis, characterization and liquid crystalline behavior of poly(monomethyl itaconate)s with new pendant cholesterol moieties. Iran Polym. J. 2013, 22:361-367.
46. Rouf M.A., Vural I., Renoir J.M., Hincal A.A. Development and characterization of liposomal formulations for rapamycin delivery and investigation of their antiproliferative effect on MCF7 cells. J. Liposome Res. 2009, 19:322-331.
47. Ghanbarzadeh S., Valizadeh H., Zakeri-Milani P. Application of factorial designs and response surface methodology in formulation development of sirolimus liposome prepared by thin film hydration technique. BioImpacts 2013, 3:75-81.
48. Ghanbarzadeh S., Valizadeh H., Zakeri-Milani P. Sirolimus nano liposomes/optimization of sirolimus nano liposomes prepared by modified ethanol injection method using response surface methodology. Pharmind 2013, (in press).
49. Ghanbarzadeh S., Valizadeh H., Zakeri-Milani P. The effects of lyophilization on the physico-chemical stability of sirolimus liposomes. Adv. Pharmaceut. Bull. 2013, 3:25-29.
50. Ghanbarzadeh S., Arami S. Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes. BioMed Research Int. 2013, (in press).
51. Nakamura K., Yamashita K., Itoh Y., Yoshino K., Nozawa S., Kasukawa H. Comparative studies of polyethylene glycol-modified liposomes prepared using different PEG-modification methods. Biochim. Biophys. Acta (BBA) - Biomembranes 2012, 1818:2801-2807.
52. Moghimi S.M., Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog. Lipid Res. 2003, 42:463-478.
53. Barenholz Y. Liposome application: problems and prospects. Curr. Opin. Colloid Interface Sci. 2001, 6:66-77.
54. Brendzel A.M., Miller I.F. Liposome filtration. Dependence on transition temperature. Biochim. Biophys. Acta (BBA) - Biomembranes 1980, 596:129-136.
55. Sułkowski W.W., Pentak D., Nowak K., Sułkowska A. The influence of temperature, cholesterol content and pH on liposome stability. J. Mol. Struct. 2005, 744-747:737-747.
56. Ducat E., Deprez J., Gillet A., Noël A., Evrard B., Peulen O., Piel G. Nuclear delivery of a therapeutic peptide by long circulating pH-sensitive liposomes: benefits over classical vesicles. Int. J. Pharm. 2011, 420:319-332.
57. Jung S.H., Kim S.K., Jung S.H., Kim E.H., Cho S.H., Jeong K.-S., Seong H., Shin B.C. Increased stability in plasma and enhanced cellular uptake of thermally denatured albumin-coated liposomes. Colloids Surf. B: Biointerfaces 2010, 76:434-440.
58. Bertrand N., Fleischer J.G., Wasan K.M., Leroux J.-C. Pharmacokinetics and biodistribution of N-isopropylacrylamide copolymers for the design of pH-sensitive liposomes. Biomaterials 2009, 30:2598-2605.
59. Meyer O., Papahadjopoulos D., Leroux J.-C. Copolymers of N-isopropylacrylamide can trigger pH sensitivity to stable liposomes. FEBS Lett. 1998, 421:61-64.
60. Momekova D., Rangelov S., Yanev S., Nikolova E., Konstantinov S., Romberg B., Storm G., Lambov N. Long-circulating, pH-sensitive liposomes sterically stabilized by copolymers bearing short blocks of lipid-mimetic units. Eur. J. Pharm. Sci. 2007, 32:308-317.
61. Yuba E., Harada A., Sakanishi Y., Watarai S., Kono K. A liposome-based antigen delivery system using pH-sensitive fusogenic polymers for cancer immunotherapy. Biomaterials 2013, 34:3042-3052.
62. Zignani M., Drummond D.C., Meyer O., Hong K., Leroux J.-C. In vitro characterization of a novel polymeric-based pH-sensitive liposome system. Biochim. Biophys. Acta (BBA) - Biomembranes 2000, 1463:383-394.